« Previous
Next »
Titles
- Manufacturers may need additional guidance to ensure consistent calculations of average sales prices1
- Medicare Part B drug payments: impact of price substitutions based on 2021 average sales prices1
- Medicare Part D: CMS should monitor effects of rebates on plan formularies and beneficiary spending : report to congressional requesters1
